NEW trial now opened by Birmingham University CLL specialists in UK to measure your response as CLL patients following vaccination

[HAIRBEAR_UK]

This is an important study to collect much needed information, please help if you can.

Details below forwarded from the trials organisers.

Covid-19 vaccine study for patients with Chronic Lymphocytic Leukaemia (CLL)

•This is a new study looking at the immune response to COVID19 vaccination amongst patients with CLL.

•There are now several COVID-19 vaccines available in the UK. Their relative efficacy in patients with CLL is not yet clear.

•We are interested to study the profile of the immune response that is elicited after vaccination in patients with CLL.

•For this study we are asking participants if they would be willing to have a blood sample taken following their first or second vaccination or to complete a home testing kit which we can send out in the post.

• If you would like to take part in this study please contact us by email at [e-mail] or call 0121-414-4491 for more info.

With best wishes,

Dr Helen Parry & Professor Paul Moss

[PaulaS]

Thanks for this, Nick. |it's great to know that this research is being done. I've just sent an email offering to take part in the study.

Best wishes,

Paula

[Youngen]

This is great! I am enrolled in a similar study in Israel. Hopefully we will see CLL specific results soon!

[2003UK]

I've already signed up for this study. Thanks Leukaemia Care

[HAIRBEAR_UK]

So the first results of this study on vaccine responses in chronic lymphocytic leukaemia patients are in and have been published in preprint in the Lancet.

"In summary, this study has shed some light on those most at risk in the CLL population and gives others cause for hope. However, we would advise that you interpret results with caution and remain vigilant against the risk of catching, as the limitations of the study prevented the researchers from being able to give further advice to patients."

In this review blog our Patient Advocacy Manager, Charlotte, outlines the first reaction to the news and what the takeaway messages are for patients and their loved ones. leukaemiacare.org.uk/suppor...

Pre- print scientific paper papers.ssrn.com/sol3/papers...

Thank you to everyone who was able to give their blood and participate in this study. As more information comes available from the study we will have a clearer picture. But what we now know is helpful to ensure we maintain vigilance.

Nick